A bill to amend the Family and Medical Leave Act of 1993 to permit leave for bone marrow or blood stem cell donation, and for other purposes.

Bill 118 s 3685, also known as the Family and Medical Leave Act (FMLA) Amendment, aims to expand the existing FMLA to allow employees to take leave for bone marrow or blood stem cell donation. The FMLA, which was originally passed in 1993, currently allows eligible employees to take up to 12 weeks of unpaid leave for certain family and medical reasons, such as the birth of a child or a serious health condition.

This new bill would specifically add bone marrow or blood stem cell donation as a qualifying reason for FMLA leave. This means that employees who need to undergo a bone marrow or blood stem cell donation procedure would be able to take time off work without fear of losing their job or benefits.

The bill does not specify the exact amount of leave that would be allowed for bone marrow or blood stem cell donation, but it would likely be similar to the 12 weeks currently allowed for other FMLA-qualifying reasons. This would give employees the necessary time to undergo the donation procedure and recover without having to worry about their job security. Overall, the FMLA Amendment Bill 118 s 3685 seeks to support and encourage bone marrow and blood stem cell donation by ensuring that employees have the time and flexibility they need to undergo these life-saving procedures. It is a bipartisan effort to improve the existing FMLA and provide additional support for individuals who choose to donate bone marrow or blood stem cells.